Birkett Bernard 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Feb 20, 2025
Insider Transaction Report
Form 4
Birkett Bernard
Sr VP, Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-02-18$211.00/sh+779.353$164,443→ 7,668.773 total - Award
Rst. Stock Unit
2025-02-18+1,740→ 1,740 totalExercise: $0.00→ Common Stock (1,740 underlying) - Tax Payment
Common Stock
2025-02-18$211.00/sh−237.764$50,168→ 7,431.009 total - Exercise/Conversion
Common Stock
2025-02-18$211.00/sh+124.977$26,370→ 7,555.986 total - Tax Payment
Common Stock
2025-02-18$211.00/sh−35.606$7,513→ 7,520.38 total - Award
Stock Option (Right to Buy)
2025-02-18+4,020→ 4,020 totalExercise: $211.00From: 2026-02-18Exp: 2035-02-18→ Common Stock (4,020 underlying)
Footnotes (1)
- [F1]This award vests in four equal installments beginning on February 18, 2026.